Signagen/GenJet™ In Vitro DNA Transfection Reagent (Ver. II)/SL100489/0.1 mL

价格
¥15760.00
货号:SL100489-5x1.0mL
浏览量:127
品牌:Signagen
服务
全国联保
正品保证
正规发票
签订合同
商品描述
GenJet™InVitroDNATransfectionReagent(VersionII)

Description
GenJet™InVitroDNATransfectionReagent(Ver.II)isupgradedversionofGenJet™InVitroDNATransfectionReagent.Adoptinganewchemistry,moreDNAcondensinggroupswereliberatedinGenJet™(Ver.II)(100%vs.80%inoldversion),leADIngto3~4foldsincreaseoftransfectionefficiencywithoutsacrificingcellviABIlity.GenJet™(Ver.II)reagent,1.0ml,issufficientfor~667transfectionsin24wellplatesor~333transfectionsin6wellplates.

FeaturescomparedwitholdversionGenJet™InVitroDNATrasnfectionReagent
-Cell-dependent3~4timeshigherefficiency
-Topchoiceforhard-to-transfectcells
-Efficiencyboostedinthepresenceofserumandantibioticsformostofcelltypes
-Exceptionalhighlevelsofrecombinantproteinproduction

StorageCondition
Storeat4°C.Ifstoredproperly,theproductisstablefor12monthsorlonger.

ComparisonsofTransfectionEfficiencyandCytotoxicityofGenJet™(Ver.II)withOldVersionGenJet™andOtherLeadingProducts

GenJet_Ver_II_vs_GenJet
Comparisonoftransfectionefficiency(leftpanel)andtoxicity(rightpanel)GenJet™Ver.IIwitholdversionGenJet™oncommonlyusedmammaliancells.phRL-CMVencodingRenillaLuciferasewasintroducedintocellswiththepresenceofserumandantibiotics.TheRenilliaLuciferaseactivitywasdeterminedwithRenillaLuciferaaseAssaySystem(Promega).Forcytotoxicity,MTTassaywasemployedtodeterminecellviabilitywithuntransfectedcontrolas100%.

GenJet_Ver_II_vs_L2K
AcomparisonoftransfectionefficiencyofGenJet™(Ver.II)vs.Lipofectamine2000onprimaryrataorticsmoothmusclecells.PrimaryrataorticsmoothmusclecellswerepreparedandtransfectedwithanucleartargetedGFPCDNAbyGenJet™(rightpanel)andLipofectamine2000(L2K,leftpanel)respectively.ThetransfectionefficiencywerecheckedunderaNikonEclipse2000fluorescencemicroscopy48hoursposttransfection

GenJet_Ver_II_vs_GenJet_HEK293
GenJet_Ver_II_vs_GenJet_HELA
UpperPanel:TransfectionefficiencycomparisonofGenJet™Ver.IIwitholdversionGenJet™on293Tcells.pEGFP-N3wastransfectedto293Tcellsat90%confluencywithpresenceofserumandantibiotics.GFPfluorescencewasdetectedwithNikonEclipse2000microscopy48hoursposttransfection
Lowerpanel:TransfectionefficiencycomparisonofGenJet™Ver.IIwitholdversionGenJet™onHelacells.pEGFP-N3wastransfectedtoHelacellsat90%confluencywithpresenceofserumandantibiotics.GFPfluorescencewasdetectedwithNikonEclipse2000microscopy48hoursposttransfection


TechnicalInformation&Datasheet
-ACompleteTransfectionProtocol
-AShortProtocolforAdvancedUsers
-AProtocolforTransfectingSUSPension293andCHOCells
AProtocolforLentivirusProduction
AProtocolrAAVProduction

-TechnicalNote&TransfectionTips


RelatedProduct:GenJet™InVitroDNATransfectionreagent

Torequestafreetrialsample,pleaseCreateAnAccountwithustoenteryourshippingaddressandemailusatorder@Signagen.com

Request a free trial sample


 

Signagen腺伴随病毒(AAV)是一种小型(直径20 nm)的复制缺陷型无包膜病毒,可感染人类和其他灵长类动物。目前尚不知道AAV会引起疾病,因此该病毒会引起非常轻微的免疫反应。AAV可以感染分裂细胞和非分裂细胞,并且可以将其基因组整合到宿主细胞的基因组中。